DISTRIBUTION AND REGULATION OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 IN MURINE ADIPOSE-TISSUE IN-VIVO - INDUCTION BY TUMOR-NECROSIS-FACTOR-ALPHA AND LIPOPOLYSACCHARIDE
F. Samad et al., DISTRIBUTION AND REGULATION OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 IN MURINE ADIPOSE-TISSUE IN-VIVO - INDUCTION BY TUMOR-NECROSIS-FACTOR-ALPHA AND LIPOPOLYSACCHARIDE, The Journal of clinical investigation, 97(1), 1996, pp. 37-46
Although elevated plasma plasminogen activator inhibitor 1 (PAI-1) is
associated with obesity, very little is known about its tissue or cell
ular origin, or about the events that lead to increased PAI-1 levels u
nder obese conditions. Since TNF-alpha is increased in rodents both du
ring obesity and in response to endotoxin treatment, we examined the e
ffects of these agents on PAI-1 gene expression in the adipose tissue
of CB6 mice, In untreated mice, PAI-1 mRNA was detected in both mature
adipocytes and in stromal vascular cells. Both TNF-alpha and endotoxi
n significantly increased PAI-1 mRNA in the adipose tissue, peaking at
3-8 h. In situ hybridization analysis of adipose tissue from untreate
d mice revealed a weak signal for PAI-1 mRNA only in the smooth muscle
cells within the vascular wall, In contrast, after endotoxin or TNF-a
lpha treatment, PAI-1 mRNA also was detected in adipocytes and in adve
ntitial cells of vessels. Endotoxin also induced PAI-1 in endothelial
cells, while TNF-alpha. additionally induced it in smooth muscle cells
. Mature 3T3-L1 adipocytes in culture also expressed PAI-1 mRNA, and i
ts rate of synthesis was also upregulated by TNF-alpha. These studies
suggest that the adipose tissue itself may be an important contributor
to the elevated PAI-1 levels observed in the plasma under obese condi
tions.